Abstract:Background Parkinson's disease (PD) is a prevailing neurodegenerative disorder increasingly affecting the elderly population. The involvement of microRNAs (miRNAs) in PD has been confirmed. We sought to explore the molecular mechanism of miR‐20a‐5p in PD. Methods Lipopolysaccharide (LPS)‐induced BV2 cell model and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine hydrochloride (MPTP‐HCl)‐induced PD mouse model were established. miR‐20a‐5p, inducible nitric oxide synthase (iNOS), interleukin (IL)‐6, tumour necrosis factor (TNF)‐α, transforming growth factor (TGF)‐β1, and IL‐10 expression in BV2 cells was examined by reverse transcription – quantitative polymerase chain reaction. Cell viability was assessed by MTT assay. The apoptotic rate and levels of Bcl‐2, Bax, cleaved caspase‐3, and signal transducer and activator of transmission (STAT)3 were examined by flow cytometry and Western blot. Bioinformatics software predicted the potential binding sites of miR‐20a‐5p and STAT3. Dual‐luciferase experiment verified the binding relationship. Iba1‐positive and tyrosine hydroxylase (TH)‐positive cell numbers in substantia nigra pars compacta were detected by immunohistochemistry. The effect of miR‐20a‐5p on motor function in MPTP‐induced PD mice was detected by Rota‐rod test, Pole test, Traction test and Beam‐crossing task. Results miR‐20a‐5p was under‐expressed in LPS‐induced BV2 cells. Overexpression of miR‐20a‐5p increased the viability of LPS‐induced BV2 cells and reduced apoptosis rates. Moreover, overexpression of miR‐20a‐5p reduced cleaved caspase‐3, Bax, iNOS, IL‐6, and TNF‐α and increased Bcl‐2 and TGF‐β1, and IL‐10. miR‐20a‐5p targeted STAT3. STAT3 overexpression partially reversed miR‐20a‐5p overexpression‐mediated effects on LPS‐induced BV2 cell viability, apoptosis, and inflammatory responses. miR‐20a‐5p overexpression inhibited MPTP‐induced STAT3 and α‐synuclein levels, microglia activation, and inflammatory response, and reduced the loss of TH‐positive cells in mice. miR‐20a‐5p overexpression ameliorated MPTP‐induced dyskinesia in PD model mice. Conclusion miR‐20a‐5p alleviates neuronal damage and suppresses inflammation by targeting STAT3 in PD.

LINC00667 Regulates MPP+‐induced Neuronal Injury in Parkinson’s Disease

Gene Expression Profiling of MPP+-treated MN9D Cells: A Mechanism of Toxicity Study

lncRNA PART1 mitigates MPP+-induced neuronal injury in SH-SY5Y cells via micRNA-106b-5p/MCL1 axis

SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to Promote MPP + -Induced Neuronal Apoptosis, Inflammation, and Oxidative Stress in Parkinson's Disease

Knockdown of SNHG14 Alleviates MPP+-Induced Injury in the Cell Model of Parkinson’s Disease by Targeting the miR-214-3p/KLF4 Axis

LncRNA MIAT Inhibits MPP+-Induced Neuronal Damage Through Regulating the miR-132/SIRT1 Axis in PC12 Cells

LncRNA SNHG1 promotes neuronal injury in Parkinson’s disease cell model by miR-181a-5p/CXCL12 axis

Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson's disease through regulating microRNA-221-3p/ transforming growth factor /nuclear factor E2-related factor 2 axis

NEAT1 enhances MPP+‐induced pyroptosis in a cell model of Parkinson's disease via targeting miR‐5047/YAF2 signaling

HMGA1 Regulates IRS2 to Promote Inflammatory Responses and Oxidative Stress Injury in MPP+-Induced cells

Long non-coding RNA SNHG1 mediates neuronal damage in Parkinson’s disease model cells by regulating miR-216a-3p/Bcl-2-associated X protein

Upregulated lncRNA small nucleolar RNA host gene 1 promotes 1‐methyl‐4‐phenylpyridinium ion‐induced cytotoxicity and reactive oxygen species production through miR‐15b‐5p/GSK3β axis in human dopaminergic SH‐SY5Y cells

Implication of the c-Jun-NH2-terminal kinase pathway in the neuroprotective effect of puerarin against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells

LncRNA HOTAIR Promotes Neuronal Damage Through Facilitating NLRP3 Mediated-Pyroptosis Activation in Parkinson’s Disease via Regulation of miR-326/ELAVL1 Axis

Circular RNA hsa_circ_0004381 Promotes Neuronal Injury in Parkinson's Disease Cell Model by miR-185-5p/RAC1 Axis

SNHG14 Upregulation Was a Molecular Mechanism Underlying MPP+ Neurotoxicity in Dopaminergic SK-N-SH Cells via SNHG14-miR-519a-3p-ATG10 ceRNA Pathway

Suppression Of Microrna-342-3p Increases Glutamate Transporters And Prevents Dopaminergic Neuron Loss Through Activating The Wnt Signaling Pathway Via P21-Activated Kinase 1 In Mice With Parkinson'S Disease

MiR-135a-5p and Mst1 regulate MPP + -1 induced apoptosis and autophagy in Parkinson's disease model in vitro

HSF1 inhibits microglia activation to attenuate neuroinflammation via regulating miR-214-3p and NFATc2 in Parkinson's disease

MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson’s disease

Regulatory mechanism of miR‐20a‐5p in neuronal damage and inflammation in lipopolysaccharide‐induced BV2 cells and MPTP‐HCl‐induced Parkinson's disease mice